Find and Pitch Jounalists, Get Your Story Covered

Tags: leukemia cancer acute promyelocytic leukemia bone marrow biopsy fever

	Profile	Recent Articles on Subject
1	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	STAT+: Early data from Arcellx, Gilead suggest CAR-T for multiple myeloma could offer safety benefit - 7 days ago
2	Amir Ali, PharmD, BCOP Pharmacy Times Clinical Hem/Onc Pharmacist. USC Assistant Professor. Founder of OncologySolutionsRx. Los Angeles, CA Healthcareoncologypharmacyeducation	Evaluating New Data for Transplant-Eligible Patients With NDMM: PERSEUS, IsKia, and GMMG HD7 - 18 days ago Impact of Transplant Eligibility on Treatment Selection - about 1 month ago
3	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Advances in CAR T-Cell Therapy and Bispecifics for Relapsed/Refractory Multiple Myeloma - 19 days ago Relapsed/Refractory Multiple Myeloma Treatment Advances With Three BiTE Therapy Options - 7 months ago Ibrutinib Plus Venetoclax With MRD-Directed Duration of Treatment Is a New Standard-of-Care Regimen for Previously Unmanaged CLL - 10 months ago AI Model Can Differentiate Prefibrotic Primary Myelofibrosis From Essential Thrombocythemia With High Accuracy - 11 months ago Ibrutinib Plus Venetoclax With MRD-Directed Duration of Treatment Is a New Standard of Care Regimen for Previously Untreated CLL - 11 months ago Prenatal Folate May Program Hematopoietic Stem Cell Function Into Adulthood - 11 months ago
4	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Real World CAR T-Cell Therapy Outcomes 'Favorable' in Relapsed/Refractory Myeloma - about 1 month ago Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers - 2 months ago FDA Panel Endorses Imetelstat for MDS-Related Anemia - 8 months ago FDA Staff Cast Doubt on Novel Drug for MDS-Related Anemia - 8 months ago All-Oral Therapy Promising in Higher-Risk MDS, CMML - 9 months ago Novel Therapy Reduced Transfusion Dependence in Lower-Risk MDS - 11 months ago
5	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Scotland first in UK to approve new myeloma treatment - 2 months ago
6	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Grants Priority Review for Asciminib for Chronic Myeloid Leukemia - 3 months ago Luspatercept Reduces Transfusion Burden Compared With Epoetin Alfa - 5 months ago FDA Approves Idecabtagene Vicleucel for Multiple Myeloma After 2 or More Lines of Therapy - 7 months ago
7	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma - 4 months ago TIL Therapy May Offer Novel Approach for Metastatic Lung Cancer - 4 months ago Why Some Myeloma Patients Refuse Stem Cell Transplant - 11 months ago
8	Shannon Firth MedPage Today Washington correspondent for MedPageToday. CUNYJschool pride. Healthcarejournalism	Fresh and Frozen Embryo Transfers May Increase Risk of Childhood Leukemia - 6 months ago
9	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	FDA Approves Earlier Use of CAR-T Products for Myeloma - 7 months ago FDA Approves First CAR-T for Chronic Lymphocytic Leukemia - 8 months ago JAK1 Inhibitor Shows 'Remarkable' Activity in T-Cell Lymphoma - 11 months ago Menin Inhibitor Yields 63% ORR in Heavily Pretreated Acute Leukemia - 11 months ago MRD Tied to Allo-Transplant Benefit in NPM1-Mutated Acute Myeloid Leukemia - 11 months ago Frontline Venetoclax-Ibrutinib for CLL Boosts Survival in Fit Patients - 11 months ago Benefits of Myeloma Regimens in the Real World Fall Well Short of Trials - 11 months ago Completely Oral Regimen Effective, Feasible in APL - 11 months ago
10	Rebecca Dyer Science Alert Science communicator. Outdoor enthusiast. Creative nerd. Comedian. Australia science communicationoutdoor activitiescreativitycomedy	Hepatitis Treatment Prevents The Progress of a Common Blood Cancer - 10 months ago

Journalists covering myeloid leukemia